Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 30;18(5):2050105.
doi: 10.1080/21645515.2022.2050105. Epub 2022 Apr 5.

The COVID-19 vaccine concerns scale: Development and validation of a new measure

Affiliations

The COVID-19 vaccine concerns scale: Development and validation of a new measure

Megan E Gregory et al. Hum Vaccin Immunother. .

Abstract

Reasons for COVID-19 hesitancy are multi-faceted and tend to differ from those for general vaccine hesitancy. We developed the COVID-19 Vaccine Concerns Scale (CVCS), a self-report measure intended to better understand individuals' concerns about COVID-19 vaccines. We validated the scale using data from a convenience sample of 2,281 emergency medical services providers, a group of professionals with high occupational COVID-19 risk. Measures included the CVCS items, an adapted Oxford COVID-19 vaccine hesitancy scale, a general vaccine hesitancy scale, demographics, and self-reported COVID-19 vaccination status. The CVCS had high internal consistency reliability (α = .89). A one-factor structure was determined by exploratory and confirmatory factor analyses (EFA and CFA), resulting in a seven-item scale. The model had good fit (X2[14] = 189.26, p < .001; CFI = .95, RMSEA = .11 [.09, .12], NNFI = .93, SRMR = .03). Moderate Pearson correlations with validated scales of general vaccine hesitancy (r = .71 , p < .001; n = 2144) and COVID-19 vaccine hesitancy (r = .82; p < .001; n = 2279) indicated construct validity. The CVCS predicted COVID-19 vaccination status (B = -2.21, Exp(B) = .11 [95% CI = .09, .13], Nagelkerke R2 = .55), indicating criterion-related validity. In sum, the 7-item CVCS is a reliable and valid self-report measure to examine fears and concerns about COVID-19 vaccines. The scale predicts COVID-19 vaccination status and can be used to inform efforts to reduce COVID-19 vaccine hesitancy.

Keywords: COVID-19; Vaccine hesitancy; scale development; scale validation; survey.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
EFA scree plot for COVID-19 vaccine concerns scale.
Figure 2.
Figure 2.
CFA results from COVID-19 vaccine concerns scale.
Figure 3.
Figure 3.
ROC curve for CVCS predicting COVID-19 vaccine status.
Figure 4.
Figure 4.
ROC curve for CVCS and general vaccine hesitancy predicting COVID-19 vaccine status.

References

    1. Centers for Disease Control and Prevention . Benefits of getting a COVID-19 vaccine. CDC; 2022 Jan 11 [accessed 2022 Jan 31]. http://www.cdc.gov/coronavirus/2019-ncov/vaccines/vaccine-benefits.html
    1. Centers for Disease Control and Prevention . COVID-19 vaccinations in the United States. 2021 Sept 15. [accessed 2021 Sept 15]. https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-total-admin-...
    1. Solis Arce J, Warren S, Meriggi N, Scacco A, McMurry N, Voors M, Syunyaev G, Malik A, Aboutajdine S, Omer S.. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. 2021;27(8):1385–7. doi: 10.1038/s41591-021-01454-y. - DOI - PMC - PubMed
    1. Edwards B, Biddle N, Gray M, Sollis K.. COVID-19 vaccine hesitancy and resistance: correlates in a nationally representative longitudinal survey of the Australian population. PLOS One. 2021;16(3):e0248892. doi: 10.1371/journal.pone.0248892. - DOI - PMC - PubMed
    1. Raciborski F, Samel-Kowalik P, Gujski M, Pinkas J, Arcimowicz M, Jankowski M. Factors associated with a lack of willingness to vaccinate against COVID-19 in Poland: a 2021 nationwide cross-sectional survey. Vaccines. 2021;9(9):1–11. doi: 10.3390/vaccines9091000. - DOI - PMC - PubMed

Publication types

Substances